Skip to main content
Premium Trial:

Request an Annual Quote

Scimagix Raises $25M in Private Financing Round

NEW YORK, July 20 – Informatics software provider Scimagix said this week that it had raised $25 million in a third found of private financing.

Dresdner Kleinwort Capital and EuclidSR Partners led the financing round. Tullis-Dickerson, Invesco, Future Capital, and IngleWood Ventures also participated in the financing round. Daniel Green, a director at Dresdner Kleinwort Capital, and Barbara Dalton, a partner at EuclidSR Partners, will take seats on the company’s board of directors.

The company will use the current round of funding to further develop its Scientific Image Management System, which can store, annotate, retrieve, and mine images from different types of experiments.

The company estimated that some 70 percent of experimental data is image-based, as opposed to numbers or text.

Scimagix of Redwood Shores, Calif., is also developing new applications for analyzing and mining different types of images. For instance, its ProteinMine software is designed to look for protein pattern in 2-D gels. The software was jointly developed with Pfizer Global R&D.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.